VC FundEIF
🇪🇺 CD3 III (Centre for Drug Design and Discovery)
KU Leuven Research & Development · Multi-Country
Focus
Health & Bio
EIF sector
Life Science
About CD3 III (Centre for Drug Design and Discovery)
CD3 III is a drug discovery fund managed by KU Leuven Research & Development through its Centre for Drug Design and Discovery, established in 2006. It invests in early-stage small-molecule drug projects drawn from academic biomedical research across Europe, alongside the European Investment Fund as a long-standing backer. Across its funds CD3 has run more than 30 drug discovery projects.
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about CD3 III (Centre for Drug Design and Discovery)
Get instant answers about CD3 III (Centre for Drug Design and Discovery) and how it fits your raise.